Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off First-Ever Study on DehydraTECH-CBD for the Potential Treatment of Diabetes
Nov 21, 2022
- In November 2021, Lexaria laid out its plans for several new and ongoing R&D programs, among them hormone replacement, dementia, rheumatoid disease, and diabetes
- The company has since begun its DIAB-A22-1 study program on the effectiveness of the patented DehydraTECH(TM)-processed CBD for the potential therapeutic utility against diabetes
- Lexaria is optimistic that the study will yield some notable results, particularly with DehydraTECH-CBD having met primary safety and efficacy objectives from its HYPER-H21-4 clinical study on the potential treatment of hypertension
- So far, CBD has shown some ability to reduce the incidence of diabetes in mice, and Lexaria looks to build on these findings and investigate DehydraTECH’s overall effectiveness for the potential treatment of the disease among human patients
- DIAB-A22-1 marks a notable milestone for Lexaria and is a testament to the company’s commitment to advancing its efforts to address unmet patient needs and create shareholder value
In November 2021, Lexaria Bioscience (NASDAQ: LEXX), a global leader in enhancing the speed and efficiency of orally-delivered fat-soluble active molecules and drugs, announced its plans for several new and ongoing research and development (“R&D”) programs on its patented DehydraTECH(TM) technology for the 2022 calendar year. The study areas included hormone replacement, dementia, rheumatoid disease, and diabetes (https://cnw.fm/SDZ4W).
On November 8, 2022, Lexaria announced that the study program, DIAB-A22-1 began on schedule, making it the company’s first-ever study to investigate whether its DehydraTECH-processed cannabidiol (“CBD”) may potentially have therapeutic utility against…
NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]
CBDWire is part of the InvestorBrandNetwork.
More News
Adidas sues Australian label White Fox over four stripes design
The German sportswear brand wants the Sydney-based label to stop selling the clothes and pay damages.
A.I. Fueled More Resilient Global Growth, W.T.O. Says
The World Trade Organization said that the drag on global trade from the war in the Middle East was more than offset by spending on goods related to artificial intelligence.
Mark Zuckerberg has an image problem - so why is Meta's business booming?
A new film paints the Meta founder as a villain. But the tech firm seems immune to bad publicity, writes our North America tech correspondent.
Why are more roofs not made of solar tiles?
Solar tiles were touted as an attractive alternative to solar panels - why have they not taken off?
'Add me on WhatsApp' scam calls to be investigated
The UK's data watchdog is investigating a spike in complaints about "robo calls" that appear to lead to a recruitment scam.
Business Daily
Economic conditions around the world are making young people rise up in protest
White House blocks Microsoft from foreign worker hiring programme
An international visa programme has for years allowed US tech companies to hire highly skilled workers from abroad.
Judge Extends Pause on Trump’s Ban Against CNN, MS NOW and Politico
The judge overseeing the case said that the pause would extend until next week, and promised to decide whether to further extend it by Tuesday.
Protesters blame 'vulture funds' for Spain's housing crisis
Hundreds have pitched their tents in central Madrid, while the Spanish prime minister has called a snap election.
Highest Mortgage Rates in 3 Years Chills the Housing Market
The average 30-year fixed-rate mortgage rose to 7.4 percent, putting more pressure on Americans struggling to afford to buy a home.
Shifting Eating Habits Have PepsiCo Investors Seeking Operational Changes
Even though sales rose in the most recent quarter, the beverage and snack company is under increasing pressure to expand its business in North America, as consumers cut costs and calories.
How soon into dating do you talk about your salary?
You've met someone and it's going well so far. But bringing up how much you both earn can be a tricky conversation.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.